IVI in the Media

04/04/2019

Neglected Victims of Neglected Diseases

The Hankook Ilbo, a leading general daily in Korea, has published an op-ed written by IVI Director General Dr. Jerome Kim. He urges Korean leaders to be the voice of the neglected to support development of vaccines against ‘tropical neglected diseases.’ — Ed.   Neglected […]
04/05/2019

Korean vaccines expanding global territory

The Seoul Economic Daily published an article in Korean about the Korean vaccine industry. The article describes the growth of the Korean vaccine industry and has two favorable mentions of IVI’s role. Shown below is a translation of the article. –Ed.   Korean vaccines expanding global territory […]
04/29/2019

IVI receives $15.7 million to conduct Ph III trials of typhoid vaccine

https://www.outsourcing-pharma.com/Article/2019/04/23/IVI-receives-15.7m-to-conduct-Ph-III-trials-of-typhoid-vaccine? Outsourcing-pharma.com,  2019/04/23
06/05/2019

Global push to find vaccine against devastating bug growing

  The Australian Broadcasting Corporation (ABC) carried a story on the new global push to develop the world’s first vaccine against Strep A in the wake of Wellcome Trust’s US$2.25 million grant to IVI and the Murdoch Children’s Research Institute. – Ed.   For most […]